Jacques Fracheboud

3.8k total citations
66 papers, 2.9k citations indexed

About

Jacques Fracheboud is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jacques Fracheboud has authored 66 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 15 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jacques Fracheboud's work include Global Cancer Incidence and Screening (58 papers), Colorectal Cancer Screening and Detection (39 papers) and Cancer Risks and Factors (29 papers). Jacques Fracheboud is often cited by papers focused on Global Cancer Incidence and Screening (58 papers), Colorectal Cancer Screening and Detection (39 papers) and Cancer Risks and Factors (29 papers). Jacques Fracheboud collaborates with scholars based in Netherlands, United States and Switzerland. Jacques Fracheboud's co-authors include Harry J. de Koning, Mireille J. M. Broeders, André L. M. Verbeek, Rob Boer, Gerrit Draisma, Suzie J. Otto, Eveline A.M. Heijnsdijk, Johanna H. Groenewoud, Jan H. C. L. Hendriks and Rianne de Gelder and has published in prestigious journals such as The Lancet, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Jacques Fracheboud

66 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacques Fracheboud Netherlands	33	2.3k	866	492	411	409	66	2.9k
Nils Bjurstam Sweden	26	2.6k 1.1×	777 0.9×	634 1.3×	405 1.0×	501 1.2×	43	3.4k
Chris de Wolf United Kingdom	11	1.3k 0.5×	544 0.6×	570 1.2×	379 0.9×	373 0.9×	19	2.0k
Bedrich Viták Sweden	24	2.7k 1.2×	987 1.1×	667 1.4×	624 1.5×	717 1.8×	35	3.7k
Nicolien T. van Ravesteyn Netherlands	23	1.8k 0.8×	504 0.6×	456 0.9×	195 0.5×	310 0.8×	71	2.4k
Debra L. Monticciolo United States	22	1.4k 0.6×	664 0.8×	482 1.0×	574 1.4×	427 1.0×	51	2.6k
G Fagerberg Sweden	20	2.5k 1.1×	1.1k 1.2×	350 0.7×	645 1.6×	302 0.7×	42	3.2k
Charles R. Smart United States	26	1.8k 0.8×	590 0.7×	703 1.4×	445 1.1×	203 0.5×	66	2.8k
Eveline A.M. Heijnsdijk Netherlands	34	1.6k 0.7×	468 0.5×	1.1k 2.3×	230 0.6×	213 0.5×	110	3.1k
Erik Thurfjell Sweden	23	1.3k 0.6×	327 0.4×	369 0.8×	321 0.8×	446 1.1×	39	1.9k
Otto Gröntoft Sweden	18	1.8k 0.8×	782 0.9×	305 0.6×	594 1.4×	288 0.7×	33	2.7k

Countries citing papers authored by Jacques Fracheboud

Since Specialization

Citations

This map shows the geographic impact of Jacques Fracheboud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Fracheboud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Fracheboud more than expected).

Fields of papers citing papers by Jacques Fracheboud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Fracheboud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Fracheboud. The network helps show where Jacques Fracheboud may publish in the future.

Co-authorship network of co-authors of Jacques Fracheboud

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Fracheboud. A scholar is included among the top collaborators of Jacques Fracheboud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Fracheboud. Jacques Fracheboud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Munck, Linda de, Sabine Siesling, Jacques Fracheboud, et al.. (2020). Impact of mammographic screening and advanced cancer definition on the percentage of advanced-stage cancers in a steady-state breast screening programme in the Netherlands. British Journal of Cancer. 123(7). 1191–1197. 12 indexed citations

Munck, Linda de, Jacques Fracheboud, Geertruida H. de Bock, et al.. (2018). Is the incidence of advanced‐stage breast cancer affected by whether women attend a steady‐state screening program?. International Journal of Cancer. 143(4). 842–850. 20 indexed citations

Heijnsdijk, Eveline A.M., Jacques Fracheboud, Lucy Overbeek, et al.. (2016). The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening. Breast Cancer Research. 18(1). 47–47. 62 indexed citations

Fracheboud, Jacques, et al.. (2013). Nation-wide data on screening performance during the transition to digital mammography: Observations in 6 million screens. European Journal of Cancer. 49(16). 3517–3525. 69 indexed citations

Otten, J.D.M., Jacques Fracheboud, Gerard J. den Heeten, et al.. (2013). Likelihood of early detection of breast cancer in relation to false-positive risk in life-time mammographic screening: population-based cohort study. Annals of Oncology. 24(10). 2501–2506. 13 indexed citations

Duijm, Lucien E. M., Marieke W.J. Louwman, Johanna H. Groenewoud, et al.. (2009). Inter-observer variability in mammography screening and effect of type and number of readers on screening outcome. British Journal of Cancer. 100(6). 901–907. 54 indexed citations

Duijm, Lucien E. M., Johanna H. Groenewoud, Jacques Fracheboud, et al.. (2008). Introduction of additional double reading of mammograms by radiographers: Effects on a biennial screening programme outcome. European Journal of Cancer. 44(9). 1223–1228. 27 indexed citations

Gelder, Rianne de, Jean‐Luc Bulliard, Chris de Wolf, et al.. (2008). Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland. European Journal of Cancer. 45(1). 127–138. 69 indexed citations

Duijm, Lucien E. M., Johanna H. Groenewoud, Jacques Fracheboud, et al.. (2008). Utilization and cost of diagnostic imaging and biopsies following positive screening mammography in the southern breast cancer screening region of the Netherlands, 2000–2005. European Radiology. 18(11). 2390–2397. 14 indexed citations

10.

Duijm, Lucien E. M., Johanna H. Groenewoud, Jacques Fracheboud, & Harry J. de Koning. (2007). Additional Double Reading of Screening Mammograms by Radiologic Technologists: Impact on Screening Performance Parameters. JNCI Journal of the National Cancer Institute. 99(15). 1162–1170. 48 indexed citations

11.

Louwman, Marieke W.J., Lonneke V. van de Poll‐Franse, Jacques Fracheboud, Jan A. Roukema, & J.W.W. Coebergh. (2007). Impact of a programme of mass mammography screening for breast cancer on socio-economic variation in survival: a population-based study. Breast Cancer Research and Treatment. 105(3). 369–375. 39 indexed citations

12.

Wildiers, Hans, Ian Kunkler, Laura Biganzoli, et al.. (2007). Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. The Lancet Oncology. 8(12). 1101–1115. 237 indexed citations

13.

Groenewoud, Johanna H., J.D.M. Otten, Jacques Fracheboud, et al.. (2006). Cost-effectiveness of different reading and referral strategies in mammography screening in the Netherlands. Breast Cancer Research and Treatment. 102(2). 211–218. 23 indexed citations

14.

Fracheboud, Jacques, Johanna H. Groenewoud, Rob Boer, et al.. (2005). Seventy‐five years is an appropriate upper age limit for population‐based mammography screening. International Journal of Cancer. 118(8). 2020–2025. 33 indexed citations

15.

Duijm, Lucien E. M., Johanna H. Groenewoud, Frits H. Jansen, et al.. (2004). Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening. British Journal of Cancer. 91(10). 1795–1799. 60 indexed citations

16.

Draisma, Gerrit, et al.. (2004). Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. British Journal of Cancer. 91(2). 242–247. 65 indexed citations

17.

Lynge, Elsebeth, Anne Helene Olsen, Jacques Fracheboud, & Julietta Patnick. (2003). Reporting of performance indicators of mammography screening in Europe. European Journal of Cancer Prevention. 12(3). 213–222. 60 indexed citations

18.

Fracheboud, Jacques, Harry J. de Koning, Petra M. M. Beemsterboer, et al.. (1999). Interval cancers in the Dutch breast cancer screening programme. British Journal of Cancer. 81(5). 912–917. 63 indexed citations

19.

Fracheboud, Jacques, Harry J. de Koning, Petra M. M. Beemsterboer, et al.. (1998). Nation-wide breast cancer screening in The Netherlands: Results of initial and subsequent screening 1990–1995. International Journal of Cancer. 75(5). 694–698. 115 indexed citations

20.

Brekelmans, Cecile T.M., et al.. (1992). Breast cancer after a negative screen: Follow-up of women participating in the DOM screening programme. European Journal of Cancer. 28(4-5). 893–895. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact